12-112869783-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001143854.2(RPH3A):c.635C>T(p.Pro212Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000157 in 1,614,088 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001143854.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPH3A | NM_001143854.2 | c.635C>T | p.Pro212Leu | missense_variant | 9/22 | ENST00000389385.9 | NP_001137326.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPH3A | ENST00000389385.9 | c.635C>T | p.Pro212Leu | missense_variant | 9/22 | 1 | NM_001143854.2 | ENSP00000374036.4 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000131 AC: 33AN: 251484Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135916
GnomAD4 exome AF: 0.000166 AC: 243AN: 1461888Hom.: 1 Cov.: 31 AF XY: 0.000158 AC XY: 115AN XY: 727246
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74410
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.635C>T (p.P212L) alteration is located in exon 9 (coding exon 7) of the RPH3A gene. This alteration results from a C to T substitution at nucleotide position 635, causing the proline (P) at amino acid position 212 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at